跳至主要内容
临床试验/CTRI/2025/03/082352
CTRI/2025/03/082352尚未招募2 期

A randomized controlled clinical trial to evaluate the efficacy of kantakaryadi arka in allergic bronchitis (Vataja Kasa)

Parul Institute of Ayurved1 个研究点 分布在 1 个国家目标入组 80 人开始时间: 2025年3月18日最近更新:

试验速览

阶段
2 期
状态
尚未招募
发起方
入组人数
80
试验地点
1
主要终点
Improvement in episodes of cough dry

研究概览

简要总结

Allergic Bronchitis is prevailed childhood illness need to be handle with active combination of  immunemodulators and antitussive agents, in present trial kantakari Arka is the similar combination used for childhood allergic bronchitis

研究设计

研究类型
Interventional
分配方式
Randomized
盲法
None

入排标准

年龄范围
5.00 Year(s) 至 12.00 Year(s)(—)
性别
All

入选标准

  • Age group between 5yrs to 12yrs.
  • Patients of either gender will be included.
  • Patients of Vataja kasa with symptoms like Shushka Kasa (dry cough), Swarbheda (hoarseness of voice), Shirashool (headache), Parshvashool and Urashool (pain in flank and chest region), Shushka mukha and gala (dryness of mouth and throat irritation).

排除标准

  • All types of Kasa except Vataja Kasa lakshana will be excluded.
  • Pneumonia, Juvenile DM, Tuberculosis, Asthma should be excluded.
  • Cough with expectoration along with fever.

结局指标

主要结局

Improvement in episodes of cough dry

时间窗: Day 1 Day 7 Day 14

次要结局

  • Improvement in cough Symptom Score(Day 1 Day 7 Day 14)

研究者

发起方
Parul Institute of Ayurved
申办方类型
Research institution and hospital
责任方
Principal Investigator
主要研究者

Dr Digvijay Singh

Parul Institute of Ayurved

研究点 (1)

Loading locations...

相似试验